Showing 1 - 12 results of 12 for search 'I. O. Stoma', query time: 0.02s Refine Results
  1. 1
    Vaccination as a strategy to overcome antimicrobial resistance: a fresh look on a well-known problem

    Vaccination as a strategy to overcome antimicrobial resistance: a fresh look on a well-known problem by I. O. Stoma

    Published 2023-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma

    Clinical and Immunological Aspects of Pneumococcal Vaccination in Patients with Multiple Myeloma by I. O. Stoma

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Possibilities and Prospects of Modification of the Intestinal Microbiome

    Possibilities and Prospects of Modification of the Intestinal Microbiome by E. G. Malaeva, I. O. Stoma

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Microbiota and Long-Term Prognosis in Liver Cirrhosis

    Microbiota and Long-Term Prognosis in Liver Cirrhosis by E. G. Malaeva, I. O. Stoma

    Published 2024-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Analyzing the Problem of Mass Rejection of Vaccination against COVID-19. Possible Solutions

    Analyzing the Problem of Mass Rejection of Vaccination against COVID-19. Possible Solutions by K. S. Korsak, E. V. Voropaev, I. O. Stoma

    Published 2022-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    The COVID-19 crisis as a vector for changes in healthcare

    The COVID-19 crisis as a vector for changes in healthcare by K. S. Korsak, E. V. Voropaev, A. A. Kovalev, T. M. Sharshakova, I. O. Stoma

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sinopharm (BBIBP-CorV), PRC)

    Study of Humoral Immunity against Coronavirus Infection COVID-19 in Vaccinated Individuals with Vaccines Available in the Republic of Belarus (Sputnik V (Gam-COVID-Vac), RF and Sin... by K. S. Korsak, I. O. Stoma, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Sarcopenia in chronic liver disease, can we predict complications?

    Sarcopenia in chronic liver disease, can we predict complications? by U. R. Salimov, I. O. Stoma, D. A. Fedoruk, A. A. Kovalev, A. E. Scherba, O. O. Rummo

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    The «microbiome» of post-liver transplant complications

    The «microbiome» of post-liver transplant complications by U. R. Salimov, I. O. Stoma, A. E. Scherba, A. M. Fedoruk, A. A. Kovalev, O. O. Rummo

    Published 2022-07-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Efficacy of COVID-19 vaccination in organized group: results of a prospective study

    Efficacy of COVID-19 vaccination in organized group: results of a prospective study by I. O. Stoma, E. S. Korsak, E. V. Voropaev, O. V. Osipkina, A. A. Kovalev, O. L. Tumash, D. D. Redko

    Published 2023-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS­-CoV-­2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)

    Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS­-CoV-­2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28) by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, D. M. Los, O. V. Osipkina, A. Yu. Braga, A. A. Kovalev, A. V. Molchanova, N. V. Trofimova, O. S. Pershenkova, B. S. Yaroshevich, M. N. Mirge

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial

    Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial by I. O. Stoma, E. V. Voropaev, E. I. Mikhailova, K. S. Korsak, O. V. Osipkina, A. V. Molchanova, A. A. Kovalev, D. M. Los, A. A. Ziatskov, A. S. Shaforost, M. N. Yatsuk, A. Yu. Braga, N. V. Trofimova, A. M. Dronina, E. L. Gasich, V. A. Gorbunov, A. Ev. Hancharou

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: